Abstract: Histopathological interpretation of proliferative nodules occurring in association with congenital melanocytic nevi can be very challenging due to their similarities with congenital malignant melanoma and malignant melanoma arising in association with congenital nevi. We hereby report a diagnostically challenging case of congenital melanocytic nevus with proliferative nodules and ulcerations, which was originally misdiagnosed as congenital malignant melanoma. Subsequent histopathological examination in consultation by one of the authors (R.L.) and mass spectrometry imaging analysis rendered a diagnosis of congenital melanocytic nevus with proliferative nodules. In this case, mass spectrometry imaging, a novel method capable of distinguishing benign from malignant melanocytic lesions on a proteomic level, was instrumental in making the diagnosis of a benign nevus. We emphasize the importance of this method as an ancillary tool in the diagnosis of difficult melanocytic lesions.
INTRODUCTION
Congenital melanocytic nevi are present in 1%-2% of newborns. Changes in its morphology are common and are usually divided into 2 main groups. The first group, which includes changes in coloration and hypertrichosis, has benign implications. However, the second group, which comprises development of nodular melanocytic lesions and ulcerations within the congenital melanocytic nevi, could signify de novo malignant melanoma arising within the nevus. [1] [2] [3] Proliferative nodules are sometimes difficult to differentiate from malignant melanoma due to the many clinical and histopathological similarities. 4, 5 Several recent studies have shown that mass spectrometry imaging (MSI) can be used to differentiate between histologically difficult lesions. Although there may be morphological features that look similar between benign and malignant lesions 6, 7 or between diseases of similar tissue origin, 8, 9 the underlying biology including proteomics between these samples is different. MSI is a natural match for pathology as the same type of thin tissue sections used for pathology are used for MSI to determine the protein composition in the tissue with the spatial information within the sample being preserved. In a recent study, we determined that 5 proteins were differentially expressed in the melanocytes of Spitz nevi and Spitzoid melanomas. 6 In a subsequent large study, MSI proved to be helpful in the classification of diagnostically challenging atypical Spitzoid neoplasms when the previously determined molecular signature was applied. 10 Furthermore, the diagnosis rendered by MSI correlated better with the clinical outcome than the histopathological diagnosis. MSI determines differences in the expression of proteins within benign and malignant melanocytic lesions of any type, which allows for their correct classification and diagnosis.
CASE REPORT
The patient was a 50-day-old healthy Chinese girl, born at term by cesarean section to a 30-year-old mother. There was no family history of melanoma. At birth, the patient had a 4.7 · 4.2 cm well-demarcated, violaceous-to-hyperpigmented plaque over the left temporoparietal area. Over a 7-week period, the lesion increased in size and became ulcerated and hemorrhagic. Physical examination revealed a 10 · 9 cm multinodular, well-demarcated, focally ulcerated plaque with variegated color and necrotic areas (Fig. 1) .
A complete excision of the entire lesion with 1-cm margin followed by a full-thickness skin graft was performed. Initial histopathological examination of the excised lesion at 2 Chinese hospitals rendered a diagnosis of malignant melanoma. When the patient was 9 months old, the case was sent for consultation to one of the authors (R.L.). The lesion showed conflicting histopathological criteria. In favor of the diagnosis of benign nevus were the presence of dense melanocytic proliferation throughout the dermis extending into the subcutaneous fat, whorled nested pattern, and monomorphous melanocytes. However, there was also prominent ulceration ( Fig. 2) , lack of maturation, mitotic figures (Fig. 3) , and melanocytes above the dermal-epidermal junction. Focal areas of necrosis within the lesion (Fig. 4) and patchy positivity of the entire lesion with HMB-45 were present (Fig. 5A) . The proliferative marker Ki-67 was positive in approximately 20% of the melanocytic nuclei (Fig. 5B ).
MATERIALS AND METHODS
We have previously used MSI to differentiate Spitz nevi from Spitzoid melanomas on a proteomic level. 6 Subsequently, we studied a melanoma from a mother and 2 atypical pigmented lesions from her newborn baby by MSI to determine whether these were metastases or atypical nevi. 11 In the current case, we used MSI to aid our diagnosis by distinguishing on a proteomic level between malignant melanoma and a nodular proliferation within a benign congenital nevus. In brief, 5-mm-thick, formalin-fixed, paraffin-embedded tissue sections were used after deparaffinization. One of the sections was placed on an indium tin oxide glass slide for mass spectral analysis and a serial section on a standard glass slide for hematoxylin and eosin staining. A digital microscopy image of the hematoxylin and eosin-stained section was acquired using a Leica SCN 400 digital microscope (Leica Biosystems, Buffalo Grove, IL) scanner. The image was annotated using custom software for areas of interest for analysis. The microscopy image was then merged with an image of the MSI slide using Adobe Photoshop software (Adobe Systems, San Jose, CA), and coordinates of the annotations were determined. Trypsin and matrix were applied to these locations using a Portrait 630 acoustic robotic microspotter (Labcyte, Inc, Sunnyvale, CA). Mass spectra were acquired from the designated locations using a Bruker AutoFlex Speed mass spectrometer operated in reflectron positive ion mode. Twenty-four areas of interest from the melanocytic component of the lesion, each measuring 300 mm in diameter, were mapped on each slide. The mass spectral profile was acquired for each one of these areas of interest. In this case, we applied the very same algorithm, classification method, and criteria that we used in our original study. 6 The resultant spectra were compared with the previously described proteomic signature composed of 5 proteins, and each area of interest was designated as either consistent with nevus or consistent with melanoma. 6 For the entire case to be diagnosed as either benign (nevus) or malignant (melanoma), an overwhelming number of the areas of interest (.66%) had to be designated by the instrument as such. A detailed description of this method and the instruments used can be found elsewhere. 6, 12 In a recent study, we compared banal melanocytic nevi with conventional malignant melanomas and determined proteomic differences, which can distinguish between the two. 13 We also applied that new algorithm to our case to ascertain whether on a proteomic level, we can distinguish between malignant melanoma and a proliferative nodule within a benign congenital nevus.
RESULTS
When using the algorithm for differentiating between Spitz nevus and Spitzoid melanoma, 17/24 spectra (71%) were in favor of a nevus, and the lesion was classified as benign. When we used the new algorithm for discriminating between banal nevi and conventional melanomas in this case, all 24 spectra (24/24, 100%) classified the lesion as benign nevus (Fig. 6 ). The patient is currently healthy and with no evidence of disease at 3.5 years of age (Fig. 7) .
DISCUSSION
Despite the rarity of malignant melanoma arising in congenital nevi, it is always a concern in rapidly enlarging, ulcerated, and hemorrhagic lesions and in lesions with a proliferative nodular pattern. 14, 15 Ulcerations and erosions, usually associated with melanoma, are generally due to skin fragility in the newborns, a mechanism not completely understood. Giam et al 1 proposed 2 possible hypotheses to explain the erosive skin changes seen in 10 patients with congenital melanocytic nevi: (1) melanocytes in the nevi possibly secrete a factor that affects the formation of basement membrane components with subsequent skin fragility; (2) there is weakening of the attachment of the basement membrane to the papillary dermis secondary to the proliferation of nevic cells at the dermal-epidermal junction. 1, 16, 17 The latter hypothesis corresponds most with our case.
Histopathological interpretation and clinical management of atypical proliferative nodules in congenital melanocytic nevi pose significant challenges due to their similarities with melanoma. 4, 5, 14 In these cases, treatment options are uncertain. Proliferative nodules show a wide spectrum of changes, including findings sometimes overlapping with those found in malignant melanoma. 17, 18 Nodular proliferations in nevi should be interpreted as benign proliferative nodules in association with a nevus if they demonstrate high cellularity, low or absent nuclear atypia, absence of necrosis and atypical mitoses, no ascent of melanocytes in the epidermis, no destructive expansive growth, a smooth transition and blending between the nodular proliferation and the adjacent nevus cells, and lack of inflammatory infiltrate. 14, 15, 18, 19 On the other hand, nodules with 2 or more of the following histopathological features are considered atypical: sharp demarcation, expansive growth, epidermal effacement, focal pagetoid spread, variable pleomorphism, 1 or more mitotic figures per high-power field, and atypical mitoses. 15, 20 Malignant melanoma should be suspected when there are large zones of necrosis, extremely atypical melanocytes, and numerous mitoses. 17, 18 In our case, there were conflicting histopathological criteria. Features suggestive of melanoma included the extensive necrosis not only of the epidermis but also of the upper half of the reticular dermis, pagetoid scatter of melanocytes in the epidermis, lack of maturation, areas of necrosis within melanocytic nests, markedly increased proliferative index with approximately 20% of the melanocytes labeling with Ki-67, and HMB-45 patchy positivity throughout the entire lesion. In contrast, the nested pattern of melanocytic proliferation, the presence of monomorphous melanocytes lacking pleomorphism, and absence of cytological atypia and atypical mitoses were features of a benign nevus. There are small numbers of reported cases in the literature of diagnostically challenging proliferative nodules within congenital melanocytic nevi (Table 1) . Proliferative nodules vary in size from a few millimeters up to 10 cm. They present with variegated color and may be ulcerated. 4, 5, 14, 21 Histopathologically, the proliferation of melanocytes is seen in the dermis and often extends to the subcutis. 4, 5, 14, 15, 21, 22 An intraepidermal component may be present. [21] [22] [23] The melanocytes are larger than those in the adjacent nevus, monomorphous, and densely packed in hypercellular areas. In rare cases, there was cytological atypia. 15 Maturation may or may not be present. Mitoses are almost invariably seen, and, in some cases, they may be as high as 27 per square millimeter. 2, 4, [24] [25] [26] Although necrosis was not identified in any of the reported cases, our case demonstrated small foci of necrosis. Between 5% and 20% of melanocytes within proliferative nodules labeled positively with the proliferative marker Ki-67. 4, 5, 15, 22 Phadke et al 20 compared Ki-67 and phosphohistone H3 (PPH3) expression levels in 18 benign and 25 atypical proliferative nodules with that of background congenital nevi and showed that Ki-67 and PPH3 scores were significantly higher in atypical proliferative nodules. Most reported cases of proliferative nodules within congenital nevi stained negative for HMB-45. In a few cases, the melanocytes of the proliferative nodules expressed HMB-45 either diffusely or focally. 15, 23, 24 In our case, there was diffuse patchy positivity with HMB-45 throughout the lesion.
Prior studies have demonstrated that melanomas and proliferative nodules, which have developed in association with congenital melanocytic nevi, show distinct patterns of genomic gains and/or losses as evaluated by comparative genomic hybridization (CGH) that can be used in their differentiation. 19, 22, 24 In proliferative nodules arising within congenital melanocytic nevi, Bastian et al 19 described a predominant pattern of gain or loss of entire chromosomes. This differed from the aberration pattern observed in melanoma, in which most cases have aberrations involving only partial chromosomes. 18 Murphy et al 22 found no chromosomal aberrations by CGH in a proliferative nodule, which developed within a congenital melanocytic nevus in a 3-month-old infant. Nguyen et al 24 reported a case of a 10-day-old boy with a giant congenital melanocytic nevus with multiple nodules. The authors documented polyploidy by fluorescence in situ hybridization in a proliferative nodule and warned against its misinterpretation as FISH-positive result. 24 Multiple whole chromosomal copy number gains by CGH were reported in a case of metastatic melanoma in association with a giant congenital melanocytic nevus in an adult. 27 We applied MSI analysis to differentiate benign proliferative nodules from melanoma in association with a large congenital nevus. The case was classified as benign. The patient is well and without recurrence or evidence of melanoma.
Our case demonstrates that mass spectrometry imaging, as an objective ancillary method using molecular and protein biomarkers, is a promising diagnostic tool in challenging and difficult melanocytic lesions. Further determining the value of this test will require larger series of cases.
